Regorafenib vs trifluridine/tipiracil for metastatic colorectal cancer refractory to standard chemotherapies: A multicenter retrospective comparison study in Japan

Misato Ogata, Masahito Kotaka, Takatsugu Ogata, Yukimasa Hatachi, Hisateru Yasui, Takeshi Kato, Akihito Tsuji, Hironaga Satake

PLoS ONE 2020 June 12; 15(6): e0234314.